Name (Synonyms) | Correlation | |
---|---|---|
drug956 | Fluvoxamine Wiki | 1.00 |
drug1822 | Placebo Wiki | 0.06 |
Name (Synonyms) | Correlation | |
---|---|---|
D007239 | Infection NIH | 0.06 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
Despite new charachersitics of COVID-19 patients, critical care implementation seems to be similar to those with Acute Respiratory Distress Syndrome (ARDS) in intensive care units (ICU). Regarding the initial gravity of these patients, sedation and neuromuscular blockers are usually administrated, increasing the risk to develope an ICU-acquired weakness which is directly correlated to morbi-mortality and a burden during recovery. Respiratory symptoms are mostly related to dyspnoea and non-productive cough, with only 33% of COVID-19 patient having a bronchial hypersecretion ; consequently, chest physiotherapy is only implemented in after case-by-case evaluation. This unprecedented situation requires to identify how physiotherapy is being implemented in COVID-19 patients in ICU. This retrospective, multicentric study aims to identify the charactheristics of physiotherapy (type and time spent) implemented in Argentina, Belgium, Chili, France, Italy and Spain
Description: Time of physiotherapy (minutes)
Measure: Time of physiotherapy Time: 1 dayDescription: Time of physiotherapy (minutes)
Measure: Time of physiotherapy Time: 3 dayDescription: Time of physiotherapy (minutes)
Measure: Time of physiotherapy Time: 7 dayDescription: Type of physiotherapy , early rehabilitation or chest phsyitoherapy
Measure: Type of physiotherapy implemented Time: 1 dayDescription: Type of physiotherapy , early rehabilitation or chest phsyitoherapy
Measure: Type of physiotherapy implemented Time: 3 dayDescription: Type of physiotherapy , early rehabilitation or chest phsyitoherapy
Measure: Type of physiotherapy implemented Time: 7 day